Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 12/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clobenzorex SCHEMBL26720 | 1.00 | LMNA (1.00) | LMNASIGMAR1POLBMAPK1CYP1A2 | |
| Clobenzorex SCHEMBL1649957 | 0.97 | LMNA (0.94) | LMNASIGMAR1POLBMAPK1CYP1A2 | |
| Clobenzorex SCHEMBL13724087 | 0.87 | LMNA (0.75) | LMNASIGMAR1POLBMAPK1CYP1A2 | |
| SCHEMBL13479679 | 0.85 | LMNA (0.74) | LMNASIGMAR1POLBMAPK1L3MBTL1 | |
| SCHEMBL8587899 | 0.83 | LMNA (0.71) | LMNASIGMAR1POLBMAPK1CYP1A2 | |
| SCHEMBL13995787 | 0.83 | LMNA (0.71) | LMNASIGMAR1POLBMAPK1CYP3A4 | |
| SCHEMBL18313993 | 0.81 | LMNA (0.69) | LMNASIGMAR1POLBMAPK1CYP1A2 | |
| SCHEMBL19772457 | 0.81 | LMNA (0.68) | LMNAPOLBMAPK1CYP3A4CYP2D6 | |
| SCHEMBL11261490 | 0.80 | LMNA (0.67) | LMNASIGMAR1POLBMAPK1CYP1A2 | |
| SCHEMBL11261494 | 0.80 | LMNA (0.67) | LMNASIGMAR1POLBMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683622-A1 | NON-DISTILLATIVE PROCESS FOR MANUFACTURING HIGH PURITY AMPHETAMINES | Pharmapotheca A, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| CN-119497589-A | Therapeutic combinations, compositions and methods for designing and producing conditions that promote mental well-being | 心境设计实验室股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| WO-2024175957-A1 | NON-DISTILLATIVE PROCESS FOR MANUFACTURING HIGH PURITY AMPHETAMINES | Pharmapotheca A, Inc. (US) | 2024-08-29 | — | — | WO | disclosed |